Kaposi Sarcoma Treatment Market to Perceive Substantial Growth During 2017–2022
Kaposi sarcoma is a malignant tumor disease majorly associated with skin, mucous membranes, lymph nodes, and other organs. Kaposi sarcoma causes lesions to grow in the skin, in the mucous membranes lining the mouth, nose, and throat, lymph nodes, and other organs. Human herpesvirus-8 (HHV-8) is majorly found in the lesion of all patients suffering from Kaposi sarcoma. However, patients with weakened immune systems by Acquired Immune Deficiency Syndrome (AIDS) disease or drugs prescribed post organ transplantation surgery are highly susceptible to HHV-8: a heterovirus, which contributes to the development of Kaposi sarcoma. Organ transplant patients are prescribed immunosuppressive agents to prevent their body from rejecting the graft, which increases their susceptibility towards Kaposi sarcoma associated herpesvirus (KSHV) infection. The long-term use of these agents increases the rate of risk of these patients by over 100 times as compared to the general population.
Get The Holistic SAMPLE With Research Methodology: https://www.coherentmarketinsights.com/insight/request-sample/1671
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma is one of the major factors driving the adoption of Highly Active Antiretroviral Therapy (HAART) therapy, which subsequently drives growth of the Kaposi sarcoma treatment market. For instance, according to the American Cancer Society (ACS), February 2016 data findings, around 1 in 200 transplant patients in the U.S. suffer from Kaposi sarcoma. In the U.S., Kaposi sarcoma is much more common among men than women, and is rarely observed among children. Additionally, according to the same source, it is more common among African Americans than in whites in the U.S in 2016.
Click To Continue Reading On Kaposi Sarcoma Treatment Market
You may be interested
Open Stack Services Market Top Manufactures, Challenges And Drivers By 2026Sayali Tribhuvan - June 24, 2018
Open Stack Services Market Research Study provide detailed information about the key factors influencing the growth of the industry which include drivers, restraints, opportunities, and industry-specific challenges,…
Power Management System Market by Products, End User, Global Forecast to 2026Sayali Tribhuvan - June 24, 2018
Power Management System Market Research Study provide detailed information about the key factors influencing the growth of the industry which include drivers, restraints, opportunities, and industry-specific challenges,…
Hydrogen Vehicle Market Positive long-term growth outlook 2018-2025Sayali Tribhuvan - June 24, 2018
Hydrogen Vehicle Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market participants in…